Pronosthyc: Prognostic factors in radioiodine refractory differentiated thyroid cancer with distant metastases, a multicentric study from the French ENDOCAN-TUTHYREF Network

Authors :: Sagnella, A.
Lasolle, H.
Godbert, Y.
Do Cao, C.
Drui, D.
Hescot, S.
Laramas, M.
Sage, C.
Wassermann, J.
Roudaut, N.
Illouz, F.
Borson-Chazot, F.
Abdelouahab, M.B.
Hadoux, J.
Borget, I.
Buffet, C.
Lamartina, L.
Source :: Annales d'Endocrinologie; October 2024, Vol. 85 Issue: 5 p387-388, 2p
Publication Year :: 2024
Abstract: Radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients with distant metastases have a heterogeneous prognosis, spanning from indolent to rapidly progressing disease. Our aim is to assess overall survival (OS) in RAI-R DTC patients and to identify the associated prognostic factors.

Full Text Access

Tools